Two important bits that I noticed were:
Slide 3
"COAST enrolment complete as of Feb 2024; ShORe estimated 2Q CY2024 (96% enrolled as of 3 April 2024)"
My thoughts: So we currently have 100% and 96% trial enrolment - that's excellent and means full enrolment very soon. Some patients may be already near to or completing the 12-month trial participation and first results may be starting to come through.
Slide 30
"Concentrated prescriptions in U.S. enables potential self commercialization opportunity with lean and targeted organization"
My thoughts: Does this mean they see themselves going alone to market (without partnership?) because they can and this pathway maximises returns to OPT?
I remain very positive for my investment in OPT.
Two important bits that I noticed were:Slide 3"COAST enrolment...
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
66.0¢ |
Change
-0.010(1.49%) |
Mkt cap ! $437.4M | |||
| Open | High | Low | Value | Volume |
| 67.0¢ | 67.0¢ | 66.0¢ | $124.7K | 188.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 41451 | 65.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 66.0¢ | 19404 | 8 |
View Market Depth
| Last trade - 14.05pm 16/05/2024 (20 minute delay) ? |
|
|||||
|
Last
65.8¢ |
Change
-0.010 ( 1.26 %) |
||||
| Open | High | Low | Volume | ||
| 66.5¢ | 67.0¢ | 65.8¢ | 29884 | ||
| Last updated 14.47pm 16/05/2024 ? | |||||
| OPT (ASX) Chart |